{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:09:48Z","timestamp":1787018988088,"version":"build-2736575974"},"reference-count":30,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Med Screen"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Lung cancer remains the leading cause of cancer-related death globally and in Belgium. Annual screening with low-dose computed tomography significantly reduces lung cancer-specific mortality in high-risk populations. Despite robust evidence supporting lung cancer screening, large-scale implementation in Belgium is still lacking. The \u2018Zuid-Oost Rand Antwerpen Lung Cancer Screening\u2019 (ZORALCS) study aims to evaluate the feasibility of introducing a regional lung cancer screening program in Flanders, specifically targeting high-risk adults with a history of heavy smoking. The primary objective is to assess the participation rate. Secondary objectives include evaluating each step of the screening and smoking cessation process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The ZORALCS study is a 4-year, prospective, non-randomized, population-based feasibility study. It targets all adults aged 55\u201374 in the South-East Region of Antwerp (ZORA), inviting 25,885 individuals by regular post. Respondents who have smoked over 100 cigarettes in their lifetime complete an online questionnaire including the PLCO\n                      <jats:sub>m2012<\/jats:sub>\n                      and HUNT risk prediction models. Those meeting risk thresholds (PLCO\n                      <jats:sub>m2012<\/jats:sub>\n                      \u2009\u20091.51% or HUNT \u22650.64%) are invited to give informed consent and undergo annual low-dose computed tomography scans for 2 years. Local authorities, healthcare professionals, and digital support services assist participants throughout the process. Scans are read by radiologists with AI support, following the latest European guidelines. Participants who currently smoke or recently quit (&lt;1 year) are enrolled in the \u2018TAbakoloog gestuurde of MInimale ROokSTOPinterventie bij longkankerscreening\u2019 (TAMIRO-STOP) randomized controlled trial to receive tailored smoking cessation support.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Expected outcomes<\/jats:title>\n                    <jats:p>Findings will help identify barriers, guide policy development, and support future national lung cancer screening implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09691413251409075","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:01:29Z","timestamp":1767114089000},"page":"110-117","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Design and rationale of the ZORALCS study: An implementation study of lung cancer screening by low-dose computed tomography coupled to a smoking cessation randomized controlled trial in the Flemish region"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7840-6819","authenticated-orcid":false,"given":"Charlotte","family":"Theuns","sequence":"first","affiliation":[{"name":"University of Antwerp"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3524-7436","authenticated-orcid":false,"given":"Amber","family":"Gerris","sequence":"additional","affiliation":[{"name":"University of Antwerp"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P","family":"van Meerbeeck","sequence":"additional","affiliation":[{"name":"University of Antwerp"},{"name":"Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Flanders, Belgium"},{"name":"Department of Radiology, Antwerp University Hospital, Edegem, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4611-4076","authenticated-orcid":false,"given":"Guido","family":"Van Hal","sequence":"additional","affiliation":[{"name":"University of Antwerp"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frele","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Radiology, Antwerp University Hospital, Edegem, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6152-2134","authenticated-orcid":false,"given":"Jan","family":"De Lepeleire","sequence":"additional","affiliation":[{"name":"KU Leuven"},{"name":"Primary Care Zone, South-East Region of Antwerp, Edegem, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6656-451X","authenticated-orcid":false,"given":"Jason","family":"Bouziotis","sequence":"additional","affiliation":[{"name":"Antwerp University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7588-4694","authenticated-orcid":false,"given":"Lauren","family":"Michiels","sequence":"additional","affiliation":[{"name":"KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaat","family":"Ramaekers","sequence":"additional","affiliation":[{"name":"Flemish Association for Respiratory Healthcare and Tuberculosis Control (VRGT)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2101-2783","authenticated-orcid":false,"given":"Annemiek","family":"Snoeckx","sequence":"additional","affiliation":[{"name":"University of Antwerp"},{"name":"Department of Radiology, Antwerp University Hospital, Edegem, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"Belgian Cancer Registry. CANCER FACT SHEET 2022 LUNG CANCER [Internet]. 2024 [cited 2024 Sep 19]. Available from: https:\/\/kankerregister.org\/sites\/default\/files\/2024\/Cancer_Fact_Sheet_Lung%20Cancer_2022.pdf."},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","unstructured":"Bonney A Malouf R Marchal C et al. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality. Vol. 2022 Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2022.","DOI":"10.1002\/14651858.CD013829.pub2"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","unstructured":"Thandra KC Barsouk A Saginala K et al. Epidemiology of lung cancer. Vol. 25 Wspolczesna Onkologia. Termedia Publishing House Ltd.; 2021. pp. 45\u201352.","DOI":"10.5114\/wo.2021.103829"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102873"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911793"},{"key":"e_1_3_3_7_2","unstructured":"CVK24-027 Verkorte Jaarfiche_DDK-BK-BHK. DEF(Hires) (1). 2024."},{"key":"e_1_3_3_8_2","unstructured":"Council of the EU. Council of the EU. [cited 2024 Feb 23]. Council updates its recommendation to screen for cancer. Available from: https:\/\/www.consilium.europa.eu\/en\/press\/press-releases\/2022\/12\/09\/council-updates-its-recommendation-to-screen-for-cancer\/. 2022."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.01.019"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.03.027"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr173"},{"key":"e_1_3_3_12_2","unstructured":"KarryAnne Belanger P. Risk Prediction Model Demonstrates Superior Performance vs. NELSON Criteria for Identifying Individuals for Screening [Internet]. 2023 [cited 2024 Feb 23]. Available from: https:\/\/www.ilcn.org\/risk-prediction-model-demonstrates-superior-performance-vs-nelson-criteria-for-identifying-individuals-for-screening\/."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002277"},{"key":"e_1_3_3_14_2","article-title":"Evaluation of risk prediction models to select lung cancer screening participants in Europe: a prospective cohort consortium analysis","volume":"6","author":"Feng X","unstructured":"Feng X, Goodley P, Alcala K, et al. Evaluation of risk prediction models to select lung cancer screening participants in Europe: a prospective cohort consortium analysis. Lancet Digit Health 2024 Sep 1; 6: e614\u2013e624.","journal-title":"Lancet Digit Health"},{"key":"e_1_3_3_15_2","article-title":"Head-to-head comparisons of risk discrimination by questionnaire-based lung cancer risk prediction models: a systematic review and meta-analysis","volume":"80","author":"Frick C","unstructured":"Frick C, Seum T, Bhardwaj M, et al. Head-to-head comparisons of risk discrimination by questionnaire-based lung cancer risk prediction models: a systematic review and meta-analysis. EClinicalMedicine 2025 Feb 1; 80.","journal-title":"EClinicalMedicine"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01278-0"},{"key":"e_1_3_3_17_2","article-title":"Improving lung cancer screening selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective Study","volume":"5","author":"Nguyen OTD","unstructured":"Nguyen OTD, Fotopoulos I, Markaki M, et al. Improving lung cancer screening selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective Study. JTO Clin Res Rep 2024 Apr 1; 5.","journal-title":"JTO Clin Res Rep"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","unstructured":"Feng X Goodley P Alcala K et al. Evaluation of risk prediction models to select lung cancer screening participants in Europe: a prospective cohort consortium analysis. Lancet Digit Health 2024; 6(9): e614\u2013e624.","DOI":"10.1016\/S2589-7500(24)00123-7"},{"key":"e_1_3_3_19_2","unstructured":"National Cancer Institute. Definition \u2013 someone who smoke [Internet]. [cited 2025 Jun 17]. Available from: https:\/\/evsexplore.semantics.cancer.gov\/evsexplore\/welcome."},{"key":"e_1_3_3_20_2","article-title":"Determinants of non-participation in population-based breast cancer screening: a systematic review and meta-analysis","volume":"12","author":"Ding L","year":"2022","unstructured":"Ding L, Wang J, Greuter MJW, et al. Determinants of non-participation in population-based breast cancer screening: a systematic review and meta-analysis. Front Oncol 2022; Vol. 12, Frontiers Media S.A..","journal-title":"Front Oncol"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-025-01591-7"},{"key":"e_1_3_3_22_2","first-page":"9","article-title":"Pratical issues in calculating the sample size for prevalence studies practical issues in calculating the sample size for prevalence studies [Internet]","volume":"1","author":"Naing L","year":"2006","unstructured":"Naing L, Naing L, Winn T, et al. Pratical issues in calculating the sample size for prevalence studies practical issues in calculating the sample size for prevalence studies [Internet]. Arch Orofac Sci 2006; 1: 9\u201314. Available from: https:\/\/www.researchgate.net\/publication\/45459002.","journal-title":"Arch Orofac Sci"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01694-7"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00124-2025"},{"key":"e_1_3_3_25_2","unstructured":"ENSP - European Network for Smoking and Tobacco Prevention. Guidelines For Treating Tobacco & Nicotine Dependence. 2025. 2025."},{"key":"e_1_3_3_26_2","unstructured":"ESTI - European Society of Thoracic Imaging. ESTI Lung Cancer Screening Certification Project - Technical standards [Internet]. 2026 [cited 2025 Aug 8]. Available from: https:\/\/www.myesti.org\/lungcancerscreeningcertificationproject\/."},{"key":"e_1_3_3_27_2","article-title":"Lung cancer screening with low-dose CT: definition of positive, indeterminate, and negative screen results. A nodule management recommendation from the European Society of Thoracic Imaging","author":"Snoeckx A","year":"2025","unstructured":"Snoeckx A, Silva M, Prosch H, et al. Lung cancer screening with low-dose CT: definition of positive, indeterminate, and negative screen results. A nodule management recommendation from the European Society of Thoracic Imaging. Eur Radiol. Springer Science and Business Media Deutschland GmbH 2025.","journal-title":"Eur Radiol. Springer Science and Business Media Deutschland GmbH"},{"key":"e_1_3_3_28_2","article-title":"Aggressiveness-guided nodule management for lung cancer screening in Europe\u2014justification for follow-up intervals and definition of growth","author":"Prokop M","year":"2025","unstructured":"Prokop M, Schaefer-Prokop C, Jacobs C, et al. Aggressiveness-guided nodule management for lung cancer screening in Europe\u2014justification for follow-up intervals and definition of growth. Eur Radiol. Springer Science and Business Media Deutschland GmbH 2025.","journal-title":"Eur Radiol. Springer Science and Business Media Deutschland GmbH"},{"key":"e_1_3_3_29_2","unstructured":"Centrum voor Kankeropsporing BCR. Jaarrapport 2016 - bevolkingsonderzoeken. 2016; 225."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-006-0532-7"},{"key":"e_1_3_3_31_2","unstructured":"Belgisch raadgevend comit\u00e9 voor bio-ethiek. Briefadvies nr. 19 van het Belgisch Raadgevend Comit\u00e9 voor Bio-ethiek betreffende het rapporteren van incidentele bevindingen tijdens verkennend onderzoek in het kader van bevolkingsscreening naar longkanker. 2024 Dec."}],"container-title":["Journal of Medical Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413251409075","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09691413251409075","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413251409075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T21:46:42Z","timestamp":1779832002000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09691413251409075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1177\/09691413251409075"],"URL":"https:\/\/doi.org\/10.1177\/09691413251409075","relation":{},"ISSN":["0969-1413","1475-5793"],"issn-type":[{"value":"0969-1413","type":"print"},{"value":"1475-5793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}